A new and alarming fungal pathogen, Candida auris (C. auris), is catalyzing a global crisis across long-term care facilities. The Centers for Disease Control and Prevention (CDC) announced C. auris to ...
An analysis of Medicare claims data found a 60-fold increase in the use of unregulated rapid molecular diagnostic tests for urinary tract infections (UTIs) in older adults from 2016 to 2023, ...
GlobalData on MSN
Co-Diagnostics files FDA 510(k) for flu and RSV PCR test
The molecular diagnostics company's concurrent CLIA Waiver by Application, if granted, would allow testing in decentralised ...
PathogenDx's Microarray Detection Platform is the fastest and most cost-effective test for UTI detection with higher throughput for efficient and accurate diagnosis. Neeraj Jadhav, Industry Analyst at ...
Last spring, a rapid polymerase chain reaction (PCR) test for COVID-19 — developed by Northwestern University spinoff company Minute Molecular Diagnostics — received emergency use authorization (EUA) ...
A recent McKnight’s article on a new consensus statement recommending against PCR urine testing in long-term care raises valid concerns about inappropriate use, particularly when results are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results